Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 62, Issue 2, Pages 567-574
Publisher
Wiley
Online
2015-01-17
DOI
10.1002/hep.27709
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
- (2014) Ezequiel Rodríguez et al. JOURNAL OF HEPATOLOGY
- Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
- (2012) Virendra Singh et al. JOURNAL OF HEPATOLOGY
- Therapeutic Response to Vasoconstrictors in Hepatorenal Syndrome Parallels Increase in Mean Arterial Pressure: A Pooled Analysis of Clinical Trials
- (2011) Juan Carlos Q. Velez et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1*
- (2011) Thomas D. Boyer et al. LIVER TRANSPLANTATION
- Liver Transplant Outcomes for Patients With Hepatorenal Syndrome Treated With Pretransplant Vasoconstrictors and Albumin
- (2011) John P. Rice et al. TRANSPLANTATION
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
- (2010) JOURNAL OF HEPATOLOGY
- Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
- (2010) Thomas D. Boyer et al. JOURNAL OF HEPATOLOGY
- Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
- (2009) André Nazar et al. HEPATOLOGY
- Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
- (2009) Lise L. Gluud et al. HEPATOLOGY
- Combination Treatment With Octreotide, Midodrine, and Albumin Improves Survival in Patients With Type 1 and Type 2 Hepatorenal Syndrome
- (2009) Catherine Skagen et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Renal Failure in Cirrhosis
- (2009) Pere Ginès et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Open Label, Pilot, Randomized Controlled Trial of NoradrenalineVersusTerlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response
- (2008) Praveen Sharma et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study
- (2008) Marta Martín–Llahí et al. GASTROENTEROLOGY
- A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome
- (2008) Arun J. Sanyal et al. GASTROENTEROLOGY
- Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis
- (2008) Paolo Angeli et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More